Skip to main content
. Author manuscript; available in PMC: 2016 Jan 1.
Published in final edited form as: Cytokine. 2014 Sep 27;71(1):71–80. doi: 10.1016/j.cyto.2014.08.007

Figure 8. Treatment with recombinant CXCL1 and CXCL2 induces more OC in Dups1−/− dOCPs.

Figure 8

(A) TRAP assay from dOCPlo, RANKL-primed cells pre-treated with recombinant CXCL1 (1ug/ml) and CXCL2 (0.3ug/ml), or vehicle then stimulated with 10ng/ml LPS for 96 hours. (B) Enumeration of recombinant cytokine treatment. Photographs are presented at 10x magnification and are representative of n=3 biological replicates. (*P<0.05, **P<0.01).